- Home
- IMOS vs SLNO Comparison
IMOS vs SLNO Comparison
Compare IMOS & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMOS | SLNO |
|---|---|---|
| Founded | 1997 | 1999 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.3B |
| IPO Year | 2007 | 2014 |
Fundamental Metrics
Financial Performance| Metric | IMOS | SLNO |
|---|---|---|
| Price | $57.99 | $53.01 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $83.00 |
| AVG Volume (30 Days) | 98.3K | ★ 1.4M |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | ★ 1.51% | N/A |
| EPS Growth | N/A | ★ 108.90 |
| EPS | N/A | ★ 0.59 |
| Revenue | N/A | ★ $1,450,788.00 |
| Revenue This Year | $21.75 | $150.46 |
| Revenue Next Year | $4.21 | $50.37 |
| P/E Ratio | $158.35 | ★ $89.83 |
| Revenue Growth | N/A | ★ 138.82 |
| 52 Week Low | $15.06 | $29.43 |
| 52 Week High | $70.99 | $89.12 |
Technical Indicators
Market Signals| Indicator | IMOS | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 53.60 | 77.32 |
| Support Level | $33.51 | $48.91 |
| Resistance Level | $61.27 | $55.47 |
| Average True Range (ATR) | 3.31 | 0.05 |
| MACD | -0.58 | -0.52 |
| Stochastic Oscillator | 47.56 | 100.00 |
Price Performance
Historical ComparisonAbout IMOS ChipMOS TECHNOLOGIES INC.
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.